Thalidomide in multiple myeloma

ONCOLOGY

Volumn 14, Issue 12 SUPPL. 13, 2000, Pages 11-16

  Rajkumar, S Vincent ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; THALIDOMIDE;

CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTIPLE MYELOMA; RECURRENT DISEASE; REVIEW;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-ALPHA; MULTIPLE MYELOMA; RECURRENCE; THALIDOMIDE;

EID: 0034576309     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7-33, 2000.
2. Bataille R, Harousseau JL: Multiple myeloma. N Engl J Med 336:1657-64, 1997.
3. Kyle RA: "Benign" monoclonal gammopathy - After 20 to 35 years of follow-up. Mayo Clin Proc 68:26-36, 1993.
4. Greipp PR, Kyle RA: Staging, kinetics, and prognosis of multiple myeloma, in Wiernik PH, Canellos GP, Dutcher JP, et al (eds): Neoplastic Diseases of the Blood, pp 537-559. New York, Churchill Livingstone, 1996.
5. Myeloma Trialists Collaborative Group: Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials. J Clin Oncol 16:3832-3842, 1998.
6. Kovacsovics T, Delaly A: Intensive treatment strategies in myeloma. Semin Hematol 34:49-60, 1997.
7. Alexanian R, Dimopoulos M: The treatment of multiple myeloma. W Engl J Med 330:484-489, 1994.
8. Oken MM, Harrington DP, Abramson N, et al: Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: Results of Eastern Cooperative Oncology Group study E2479. Cancer 79:1561-1567, 1997.
9. Harousseau JL, Attal M: The role of autologous hematopoietic stem cell transplantation in multiple myeloma. Semin Hematol 34:61-66, 1997.
10. Barlogie B, Jagannath S, Epstein J, et al: Biology and therapy of multiple myeloma in 1996. Semin Hematol 34:67-72, 1997.
11. Gertz MA, Pineda AA, Chen MG, et al: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am J Med Sci 309:152-161, 1995.
12. Attal M, Harousseau JL, Stoppa AM, et al: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 335:91-97, 1996.